- Report
- October 2024
- 800 Pages
Global
From €3787EUR$3,995USD£3,163GBP
- Report
- February 2025
- 198 Pages
Global
From €2322EUR$2,450USD£1,940GBP
- Report
- October 2024
- 189 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- October 2024
- 194 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- September 2024
- 100 Pages
Global
From €5640EUR$5,950USD£4,711GBP
- Report
- February 2025
- 136 Pages
Global
From €2843EUR$2,999USD£2,375GBP
- Report
- September 2024
- 137 Pages
Global
From €2843EUR$2,999USD£2,375GBP
- Report
- August 2024
- 143 Pages
Global
From €2843EUR$2,999USD£2,375GBP
- Report
- August 2024
- 148 Pages
Global
From €2843EUR$2,999USD£2,375GBP
- Report
- April 2025
- 254 Pages
Global
From €4692EUR$4,950USD£3,920GBP
- Report
- April 2025
- 89 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- April 2025
- 158 Pages
Global
From €5166EUR$5,450USD£4,316GBP
- Report
- April 2025
- 171 Pages
Global
From €5166EUR$5,450USD£4,316GBP
- Report
- March 2025
- 175 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- March 2025
- 250 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- March 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- January 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- March 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP

The Communicable Disease Control market is a subset of the Infectious Disease Testing market, focusing on the prevention, diagnosis, and treatment of communicable diseases. This market includes products and services such as diagnostic tests, vaccines, and therapeutics. Diagnostic tests are used to detect the presence of a communicable disease, while vaccines are used to prevent the spread of communicable diseases. Therapeutics are used to treat communicable diseases.
The Communicable Disease Control market is driven by the increasing prevalence of communicable diseases, the growing demand for rapid and accurate diagnosis, and the increasing availability of vaccines. Additionally, the increasing focus on public health initiatives and the development of new technologies are expected to drive the market.
Some companies in the Communicable Disease Control market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more